Jiangsu Hengrui Medicine
600276.SS
#509
Rank
โ‚ฌ36.55 B
Marketcap
5,73ย โ‚ฌ
Share price
-0.27%
Change (1 day)
0.35%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ5.98 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are โ‚ฌ5.98 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31โ‚ฌ5.72 B5.7%
2021-12-31โ‚ฌ5.41 B24.34%
2020-12-31โ‚ฌ4.35 B23.99%
2019-12-31โ‚ฌ3.51 B22.94%
2018-12-31โ‚ฌ2.85 B23.65%
2017-12-31โ‚ฌ2.31 B17.79%
2016-12-31โ‚ฌ1.96 B20.75%
2015-12-31โ‚ฌ1.62 B34.78%
2014-12-31โ‚ฌ1.20 B39.59%
2013-12-31โ‚ฌ0.86 B20.77%
2012-12-31โ‚ฌ0.71 B21.14%
2011-12-31โ‚ฌ0.59 B32.94%
2010-12-31โ‚ฌ0.44 B44.79%
2009-12-31โ‚ฌ0.30 B30.76%
2008-12-31โ‚ฌ0.23 B22.55%
2007-12-31โ‚ฌ0.19 B34.23%
2006-12-31โ‚ฌ0.14 B6.02%
2005-12-31โ‚ฌ0.13 B33.88%
2004-12-31โ‚ฌ0.10 B-28.5%
2003-12-31โ‚ฌ0.14 B0.91%
2002-12-31โ‚ฌ0.13 B-9.06%
2001-12-31โ‚ฌ0.15 B